
Ranked nationally in pediatric care.
Arkansas Children's provides right-sized care for your child. U.S. News & World Report has ranked Arkansas Children's in seven specialties for 2024-2025.

It's easier than ever to sign up for MyChart.
Sign up online to quickly and easily manage your child's medical information and connect with us whenever you need.

We're focused on improving child health through exceptional patient care, groundbreaking research, continuing education, and outreach and prevention.

When it comes to your child, every emergency is a big deal.
Our ERs are staffed 24/7 with doctors, nurses and staff who know kids best – all trained to deliver right-sized care for your child in a safe environment.

Arkansas Children's provides right-sized care for your child. U.S. News & World Report has ranked Arkansas Children's in seven specialties for 2024-2025.

Looking for resources for your family?
Find health tips, patient stories, and news you can use to champion children.

Support from the comfort of your home.
Our flu resources and education information help parents and families provide effective care at home.

Children are at the center of everything we do.
We are dedicated to caring for children, allowing us to uniquely shape the landscape of pediatric care in Arkansas.

Transforming discovery to care.
Our researchers are driven by their limitless curiosity to discover new and better ways to make these children better today and healthier tomorrow.

We're focused on improving child health through exceptional patient care, groundbreaking research, continuing education, and outreach and prevention.

Then we're looking for you! Work at a place where you can change lives...including your own.

When you give to Arkansas Children's, you help deliver on our promise of a better today and a healthier tomorrow for the children of Arkansas and beyond

Become a volunteer at Arkansas Children's.
The gift of time is one of the most precious gifts you can give. You can make a difference in the life of a sick child.

Join our Grassroots Organization
Support and participate in this advocacy effort on behalf of Arkansas’ youth and our organization.

Learn How We Transform Discovery to Care
Scientific discoveries lead us to new and better ways to care for children.

Learn How We Transform Discovery to Care
Scientific discoveries lead us to new and better ways to care for children.

Learn How We Transform Discovery to Care
Scientific discoveries lead us to new and better ways to care for children.

Learn How We Transform Discovery to Care
Scientific discoveries lead us to new and better ways to care for children.

Learn How We Transform Discovery to Care
Scientific discoveries lead us to new and better ways to care for children.

Learn How We Transform Discovery to Care
Scientific discoveries lead us to new and better ways to care for children.

When you give to Arkansas Children’s, you help deliver on our promise of a better today and a healthier tomorrow for the children of Arkansas and beyond.

Your volunteer efforts are very important to Arkansas Children's. Consider additional ways to help our patients and families.

Join one of our volunteer groups.
There are many ways to get involved to champion children statewide.

Make a positive impact on children through philanthropy.
The generosity of our supporters allows Arkansas Children's to deliver on our promise of making children better today and a healthier tomorrow.

Read and watch heart-warming, inspirational stories from the patients of Arkansas Children’s.
Hello.
Arkansas Children's Hospital
General Information 501-364-1100
Arkansas Children's Northwest
General Information 479-725-6800

Cancer and Blood Disorders Program
Our expert doctors and care teams are highly skilled in diagnosing, evaluating, and treating childhood problems related to blood and tumors.
General Information: 501-364-4000
At Arkansas Children’s, your child will have access to a wide range of treatments, from traditional to experimental.
Possible Treatments
- Multidisciplinary diagnostic evaluation
- Chemotherapy infusions
- Clinical trial access
- Autologous and allogeneic bone marrow transplant
- Supportive care infusions
- Experimental therapeutics
Clinical Trials
As a respected leader in pediatric cancer treatment, Arkansas Children's is a member of several groups dedicated to improving the lives of children and families living with cancer and blood disorders. Membership in these groups lets your child receive cutting-edge treatments and take part in clinical trials.
At Arkansas Children’s, we are members of:
- Children's Oncology Group (COG). COG provides information and support to help children and their families in the fight against cancer.
- Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC). POETIC is a group of 10 large academic medical centers in North America with a major emphasis on comprehensive cancer care and research.
- Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC). The NMTRC is a group of 25 universities and children’s hospitals that create a nationwide network of childhood cancer clinical trials. These trials are developing novel therapies for high-risk neuroblastoma and medulloblastoma.
Currently Enrolling Studies
-
Clinical Trial
Immune Thrombocytopenic Purpura and Sports
We want to understand the impact of sport and activity restrictions on children with ITP and their families.
-
Clinical Trial
Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
This study initially aims to evaluate the safety and tolerability of tipifarnib when combined with naxitamab in pediatric and young adult patients.
-
Clinical Trial
TINI 2: Total Therapy for Infants with Acute Lymphoblastic Leukemia II
The goals of this study are to increase disease clearance and sustain deep remission through the use of the immunotherapy agent, blinatumomab.
-
Clinical Trial
Oral Health in patients with Immune Thrombocytopenia
Help us learn more about how ITP affects the oral health of patients.
-
Clinical Trial
SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers
Learn more about SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers. Through this study, we are working to better understand how SCD impacts the developing brain.
-
Clinical Trial
BCC 016 A Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
This study seeks to evaluate how well the DFMO works to prevent relapse in patients with high risk and very high risk medulloblastoma.
-
Clinical Trial
A PHASE I/IIA STUDY OF 2-HYDROXYOLEIC ACID IN PEDIATRIC PATIENTS WITH MALIGNANT GLIOMA AND OTHER ADVANCED SOLID TUMORS
This study is a phase I/IIa study of 2-Hydroxyoleic acid in pediatric patients with malignant glioma and other advanced solid tumors.
-
Clinical Trial
UNITCALL Study
We are looking for children between the ages of 3 and 10 to help us learn about typical brain development. Learn more about the Unitcall clinical trial.
-
Clinical Trial
PARPAML: A Phase 1 Protocol for Relapsed Pediatric AML to Determine the Safety and Efficacy of the PARP Inhibitor Talazoparib in Combination with Chemotherapy
The purpose of this study is to find out what effects study treatment with talazoparib in combination with conventional chemotherapy agents topotecan and gemcitabine has on you and your cancer.
-
Clinical Trial
A Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease, and Other Histiocytic Disorders
Learn more about a Phase 2 Study to assess the safety and efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease.
-
Clinical Trial
A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma
This multicenter clinical trial is studying the safety and efficacy of the monoclonal antibody naxitamab, combined with standard induction treatment, in children newly diagnosed with high-risk neuroblastoma.
-
Hospital Services
Send an E-card
Bookmark Send an E-cardBrighten the day of the patient by sending a word of encouragement.
-
Hospital Services
Child Life
Bookmark Child LifeChild Life reduces stress and promotes positive coping using developmentally appropriate preparation, education, and play at Arkansas Children's.
-
Amenities
Hospital Amenities
Bookmark Hospital AmenitiesArkansas Children's offers on-site dining, shuttle services, and gift shops, as well as discounted hotels and RV parks nearby.
Conditions
Jump to
Overview
Conditions
Treatments
Health at Home
At Arkansas Children’s, your child will have access to a wide range of treatments, from traditional to experimental.
Possible Treatments
- Multidisciplinary diagnostic evaluation
- Chemotherapy infusions
- Clinical trial access
- Autologous and allogeneic bone marrow transplant
- Supportive care infusions
- Experimental therapeutics
Clinical Trials
As a respected leader in pediatric cancer treatment, Arkansas Children's is a member of several groups dedicated to improving the lives of children and families living with cancer and blood disorders. Membership in these groups lets your child receive cutting-edge treatments and take part in clinical trials.
At Arkansas Children’s, we are members of:
- Children's Oncology Group (COG). COG provides information and support to help children and their families in the fight against cancer.
- Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC). POETIC is a group of 10 large academic medical centers in North America with a major emphasis on comprehensive cancer care and research.
- Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC). The NMTRC is a group of 25 universities and children’s hospitals that create a nationwide network of childhood cancer clinical trials. These trials are developing novel therapies for high-risk neuroblastoma and medulloblastoma.
Currently Enrolling Studies
-
Clinical Trial
Immune Thrombocytopenic Purpura and Sports
We want to understand the impact of sport and activity restrictions on children with ITP and their families.
-
Clinical Trial
Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
This study initially aims to evaluate the safety and tolerability of tipifarnib when combined with naxitamab in pediatric and young adult patients.
-
Clinical Trial
TINI 2: Total Therapy for Infants with Acute Lymphoblastic Leukemia II
The goals of this study are to increase disease clearance and sustain deep remission through the use of the immunotherapy agent, blinatumomab.
-
Clinical Trial
Oral Health in patients with Immune Thrombocytopenia
Help us learn more about how ITP affects the oral health of patients.
-
Clinical Trial
SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers
Learn more about SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers. Through this study, we are working to better understand how SCD impacts the developing brain.
-
Clinical Trial
BCC 016 A Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
This study seeks to evaluate how well the DFMO works to prevent relapse in patients with high risk and very high risk medulloblastoma.
-
Clinical Trial
A PHASE I/IIA STUDY OF 2-HYDROXYOLEIC ACID IN PEDIATRIC PATIENTS WITH MALIGNANT GLIOMA AND OTHER ADVANCED SOLID TUMORS
This study is a phase I/IIa study of 2-Hydroxyoleic acid in pediatric patients with malignant glioma and other advanced solid tumors.
-
Clinical Trial
UNITCALL Study
We are looking for children between the ages of 3 and 10 to help us learn about typical brain development. Learn more about the Unitcall clinical trial.
-
Clinical Trial
PARPAML: A Phase 1 Protocol for Relapsed Pediatric AML to Determine the Safety and Efficacy of the PARP Inhibitor Talazoparib in Combination with Chemotherapy
The purpose of this study is to find out what effects study treatment with talazoparib in combination with conventional chemotherapy agents topotecan and gemcitabine has on you and your cancer.
-
Clinical Trial
A Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease, and Other Histiocytic Disorders
Learn more about a Phase 2 Study to assess the safety and efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease.
-
Clinical Trial
A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma
This multicenter clinical trial is studying the safety and efficacy of the monoclonal antibody naxitamab, combined with standard induction treatment, in children newly diagnosed with high-risk neuroblastoma.
-
Hospital Services
Send an E-card
Bookmark Send an E-cardBrighten the day of the patient by sending a word of encouragement.
-
Hospital Services
Child Life
Bookmark Child LifeChild Life reduces stress and promotes positive coping using developmentally appropriate preparation, education, and play at Arkansas Children's.
-
Amenities
Hospital Amenities
Bookmark Hospital AmenitiesArkansas Children's offers on-site dining, shuttle services, and gift shops, as well as discounted hotels and RV parks nearby.
Treatments
Jump to
Overview
Conditions
Treatments
Health at Home
At Arkansas Children’s, your child will have access to a wide range of treatments, from traditional to experimental.
Possible Treatments
- Multidisciplinary diagnostic evaluation
- Chemotherapy infusions
- Clinical trial access
- Autologous and allogeneic bone marrow transplant
- Supportive care infusions
- Experimental therapeutics
Clinical Trials
As a respected leader in pediatric cancer treatment, Arkansas Children's is a member of several groups dedicated to improving the lives of children and families living with cancer and blood disorders. Membership in these groups lets your child receive cutting-edge treatments and take part in clinical trials.
At Arkansas Children’s, we are members of:
- Children's Oncology Group (COG). COG provides information and support to help children and their families in the fight against cancer.
- Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC). POETIC is a group of 10 large academic medical centers in North America with a major emphasis on comprehensive cancer care and research.
- Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC). The NMTRC is a group of 25 universities and children’s hospitals that create a nationwide network of childhood cancer clinical trials. These trials are developing novel therapies for high-risk neuroblastoma and medulloblastoma.
Currently Enrolling Studies
-
Clinical Trial
Immune Thrombocytopenic Purpura and Sports
We want to understand the impact of sport and activity restrictions on children with ITP and their families.
-
Clinical Trial
Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
This study initially aims to evaluate the safety and tolerability of tipifarnib when combined with naxitamab in pediatric and young adult patients.
-
Clinical Trial
TINI 2: Total Therapy for Infants with Acute Lymphoblastic Leukemia II
The goals of this study are to increase disease clearance and sustain deep remission through the use of the immunotherapy agent, blinatumomab.
-
Clinical Trial
Oral Health in patients with Immune Thrombocytopenia
Help us learn more about how ITP affects the oral health of patients.
-
Clinical Trial
SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers
Learn more about SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers. Through this study, we are working to better understand how SCD impacts the developing brain.
-
Clinical Trial
BCC 016 A Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
This study seeks to evaluate how well the DFMO works to prevent relapse in patients with high risk and very high risk medulloblastoma.
-
Clinical Trial
A PHASE I/IIA STUDY OF 2-HYDROXYOLEIC ACID IN PEDIATRIC PATIENTS WITH MALIGNANT GLIOMA AND OTHER ADVANCED SOLID TUMORS
This study is a phase I/IIa study of 2-Hydroxyoleic acid in pediatric patients with malignant glioma and other advanced solid tumors.
-
Clinical Trial
UNITCALL Study
We are looking for children between the ages of 3 and 10 to help us learn about typical brain development. Learn more about the Unitcall clinical trial.
-
Clinical Trial
PARPAML: A Phase 1 Protocol for Relapsed Pediatric AML to Determine the Safety and Efficacy of the PARP Inhibitor Talazoparib in Combination with Chemotherapy
The purpose of this study is to find out what effects study treatment with talazoparib in combination with conventional chemotherapy agents topotecan and gemcitabine has on you and your cancer.
-
Clinical Trial
A Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease, and Other Histiocytic Disorders
Learn more about a Phase 2 Study to assess the safety and efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease.
-
Clinical Trial
A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma
This multicenter clinical trial is studying the safety and efficacy of the monoclonal antibody naxitamab, combined with standard induction treatment, in children newly diagnosed with high-risk neuroblastoma.
-
Hospital Services
Send an E-card
Bookmark Send an E-cardBrighten the day of the patient by sending a word of encouragement.
-
Hospital Services
Child Life
Bookmark Child LifeChild Life reduces stress and promotes positive coping using developmentally appropriate preparation, education, and play at Arkansas Children's.
-
Amenities
Hospital Amenities
Bookmark Hospital AmenitiesArkansas Children's offers on-site dining, shuttle services, and gift shops, as well as discounted hotels and RV parks nearby.
Health at Home
Jump to
Overview
Conditions
Treatments
Health at Home
At Arkansas Children’s, your child will have access to a wide range of treatments, from traditional to experimental.
Possible Treatments
- Multidisciplinary diagnostic evaluation
- Chemotherapy infusions
- Clinical trial access
- Autologous and allogeneic bone marrow transplant
- Supportive care infusions
- Experimental therapeutics
Clinical Trials
As a respected leader in pediatric cancer treatment, Arkansas Children's is a member of several groups dedicated to improving the lives of children and families living with cancer and blood disorders. Membership in these groups lets your child receive cutting-edge treatments and take part in clinical trials.
At Arkansas Children’s, we are members of:
- Children's Oncology Group (COG). COG provides information and support to help children and their families in the fight against cancer.
- Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC). POETIC is a group of 10 large academic medical centers in North America with a major emphasis on comprehensive cancer care and research.
- Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC). The NMTRC is a group of 25 universities and children’s hospitals that create a nationwide network of childhood cancer clinical trials. These trials are developing novel therapies for high-risk neuroblastoma and medulloblastoma.
Currently Enrolling Studies
-
Clinical Trial
Immune Thrombocytopenic Purpura and Sports
We want to understand the impact of sport and activity restrictions on children with ITP and their families.
-
Clinical Trial
Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
This study initially aims to evaluate the safety and tolerability of tipifarnib when combined with naxitamab in pediatric and young adult patients.
-
Clinical Trial
TINI 2: Total Therapy for Infants with Acute Lymphoblastic Leukemia II
The goals of this study are to increase disease clearance and sustain deep remission through the use of the immunotherapy agent, blinatumomab.
-
Clinical Trial
Oral Health in patients with Immune Thrombocytopenia
Help us learn more about how ITP affects the oral health of patients.
-
Clinical Trial
SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers
Learn more about SoNIC Teens Study: Sickle Cell Neurological Impact and Cognition in Teenagers. Through this study, we are working to better understand how SCD impacts the developing brain.
-
Clinical Trial
BCC 016 A Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
This study seeks to evaluate how well the DFMO works to prevent relapse in patients with high risk and very high risk medulloblastoma.
-
Clinical Trial
A PHASE I/IIA STUDY OF 2-HYDROXYOLEIC ACID IN PEDIATRIC PATIENTS WITH MALIGNANT GLIOMA AND OTHER ADVANCED SOLID TUMORS
This study is a phase I/IIa study of 2-Hydroxyoleic acid in pediatric patients with malignant glioma and other advanced solid tumors.
-
Clinical Trial
UNITCALL Study
We are looking for children between the ages of 3 and 10 to help us learn about typical brain development. Learn more about the Unitcall clinical trial.
-
Clinical Trial
PARPAML: A Phase 1 Protocol for Relapsed Pediatric AML to Determine the Safety and Efficacy of the PARP Inhibitor Talazoparib in Combination with Chemotherapy
The purpose of this study is to find out what effects study treatment with talazoparib in combination with conventional chemotherapy agents topotecan and gemcitabine has on you and your cancer.
-
Clinical Trial
A Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease, and Other Histiocytic Disorders
Learn more about a Phase 2 Study to assess the safety and efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease.
-
Clinical Trial
A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma
This multicenter clinical trial is studying the safety and efficacy of the monoclonal antibody naxitamab, combined with standard induction treatment, in children newly diagnosed with high-risk neuroblastoma.
-
Hospital Services
Send an E-card
Bookmark Send an E-cardBrighten the day of the patient by sending a word of encouragement.
-
Hospital Services
Child Life
Bookmark Child LifeChild Life reduces stress and promotes positive coping using developmentally appropriate preparation, education, and play at Arkansas Children's.
-
Amenities
Hospital Amenities
Bookmark Hospital AmenitiesArkansas Children's offers on-site dining, shuttle services, and gift shops, as well as discounted hotels and RV parks nearby.
Arkansas Children's MyChart
Manage your child's medical information and connect with your Arkansas Children's medical team anytime online!
Log in to MyChart-
Hospital Services
Hospital Resources
Bookmark Hospital ResourcesAccess the information and tools you need to stay connected with Arkansas Children's quickly.
-
Hospital Services
Interpreter Services
Bookmark Interpreter ServicesArkansas Children's offers translation assistance to the hearing impaired as well as non-English speaking patients and families.
-
Hospital Services
Refer a Patient
Bookmark Refer a PatientArkansas Children's offers comprehensive care to patients through a physician referral.